Atosiban Impurity D is a structurally related byproduct formed during atosiban synthesis, differing subtly in side-chain or ring connectivity. Researchers analyze its chromatographic resolution and spectral signature. The peptide aids in verifying impurity limits and method selectivity. Applications include quality control, peptide-process mapping, and degradation-pathway elucidation.
CAT No: Z10-101-222
Synonyms/Alias:N4-((2R)-1-((2S)-2-((5-amino-1-((2-amino-2-oxoethyl)amino)-1-oxopentan-2-yl)carbamoyl)pyrrolidin-1-yl)-3-mercapto-1-oxopropan-2-yl)-N2-((R)-3-(4-ethoxyphenyl)-2-(3-mercaptopropanamido)propanoyl)-L-isoleucyl-L-threonyl-L-asparagine;
1. Immune-awakening Saccharomyces-inspired nanocarrier for oral target delivery to lymph and tumors
2. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment
3. Urinary Metabolites Associated with Blood Pressure on a Low-or High-Sodium Die
5. Adipose tissue is a key organ for the beneficial effects of GLP-2 metabolic function
If you have any peptide synthesis requirement in mind, please do not hesitate to contact us at . We will endeavor to provide highly satisfying products and services.
Creative Peptides is a trusted CDMO partner specializing in high-quality peptide synthesis, conjugation, and manufacturing under strict cGMP compliance. With advanced technology platforms and a team of experienced scientists, we deliver tailored peptide solutions to support drug discovery, clinical development, and cosmetic innovation worldwide.
From custom peptide synthesis to complex peptide-drug conjugates, we provide flexible, end-to-end services designed to accelerate timelines and ensure regulatory excellence. Our commitment to quality, reliability, and innovation has made us a preferred partner across the pharmaceutical, biotechnology, and personal care industries.
Read More